Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells

Mutations in the Parkinson’s disease (PD) protein Leucine Rich Repeat Kinase 2 (LRRK2) have been under study for more than 15 years and our understanding of the cellular phenotypes for the pathogenic mutant forms of LRRK2 has significantly advanced. In parallel to research on LRRK2 mutations in expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Goveas, Liesel, Mutez, Eugénie, Chartier-Harlin, Marie-Christine, Taymans, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145309/
https://www.ncbi.nlm.nih.gov/pubmed/33922322
http://dx.doi.org/10.3390/cells10050981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145309/
https://www.ncbi.nlm.nih.gov/pubmed/33922322
http://dx.doi.org/10.3390/cells10050981

Ejemplares similares